RNASEH1 Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 2 Autosomal Recessive Genetic Test sale cost 4400 AED
TSEN34 Gene Pontocerebellar Hypoplasia Type 2C Genetic Test sale cost 4400 AED TSEN34 Gene Pontocerebellar Hypoplasia Type 2C Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
SRPX2 Gene Rolandic Epilepsy Mental Retardation and Speech Dyspraxia Genetic Test sale cost 4400 AED SRPX2 Gene Rolandic Epilepsy Mental Retardation and Speech Dyspraxia Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

RNASEH1 Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 2 Autosomal Recessive Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The RNASEH1 gene plays a crucial role in maintaining the integrity of mitochondrial DNA, which is essential for normal cellular energy production. Mutations in the RNASEH1 gene can lead to Progressive External Ophthalmoplegia with Mitochondrial Deletions, Type 2, an autosomal recessive disorder. This condition is characterized by weakness in the muscles that control eye and eyelid movement, leading to drooping eyelids (ptosis) and difficulty moving the eyes, which can result in double vision. Additionally, affected individuals may experience muscle weakness in other parts of the body.

To diagnose this condition, a genetic test targeting the RNASEH1 gene can be performed. DNA Labs UAE offers this specialized genetic test, which is designed to identify mutations in the RNASEH1 gene that are associated with the development of Progressive External Ophthalmoplegia with Mitochondrial Deletions, Type 2. The test is crucial for confirming the diagnosis, understanding the disease’s progression, and guiding treatment options.

The cost of the RNASEH1 gene genetic test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the RNASEH1 gene. This test is an important tool for individuals experiencing symptoms of Progressive External Ophthalmoplegia with Mitochondrial Deletions, Type 2, or for those with a family history of the condition, as it can provide a definitive diagnosis and facilitate appropriate management and genetic counseling.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

RNASEH1 Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 2 Autosomal Recessive Genetic Test

Test Name: RNASEH1 Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 2 Autosomal Recessive Genetic Test

Components: RNASEH1 Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 2 Autosomal Recessive Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for RNASEH1 Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 2 Autosomal Recessive NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RNASEH1 Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 2 Autosomal Recessive.

Test Details: The RNASEH1 gene is associated with a condition called progressive external ophthalmoplegia with mitochondrial deletions type 2 (PEO2). This condition is inherited in an autosomal recessive manner, which means that both copies of the gene must have a mutation for the individual to be affected. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced technology to analyze multiple genes simultaneously. In the case of PEO2, NGS can be used to identify mutations in the RNASEH1 gene that may be causing the condition. By identifying mutations in the RNASEH1 gene, NGS genetic testing can help confirm a diagnosis of PEO2 and provide information about the specific genetic changes that are present. This information can be useful for understanding the underlying cause of the condition, predicting the likelihood of passing it on to future generations, and potentially guiding treatment options. It is important to consult with a healthcare professional or genetic counselor for a comprehensive evaluation and to discuss the implications of genetic testing for PEO2. They can provide more detailed information about the specific genetic test, its limitations, and its potential benefits.

Test Name RNASEH1 Gene Progressive external ophthalmoplegia with mitochondrial deletions type 2 autosomal recessive Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for RNASEH1 Gene Progressive external ophthalmoplegia with mitochondrial deletions type 2, autosomal recessive NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with RNASEH1 Gene Progressive external ophthalmoplegia with mitochondrial deletions type 2, autosomal recessive
Test Details

The RNASEH1 gene is associated with a condition called progressive external ophthalmoplegia with mitochondrial deletions type 2 (PEO2). This condition is inherited in an autosomal recessive manner, which means that both copies of the gene must have a mutation for the individual to be affected.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced technology to analyze multiple genes simultaneously. In the case of PEO2, NGS can be used to identify mutations in the RNASEH1 gene that may be causing the condition.

By identifying mutations in the RNASEH1 gene, NGS genetic testing can help confirm a diagnosis of PEO2 and provide information about the specific genetic changes that are present. This information can be useful for understanding the underlying cause of the condition, predicting the likelihood of passing it on to future generations, and potentially guiding treatment options.

It is important to consult with a healthcare professional or genetic counselor for a comprehensive evaluation and to discuss the implications of genetic testing for PEO2. They can provide more detailed information about the specific genetic test, its limitations, and its potential benefits.

SKU: TEST-1942 Category:

Related products